Abstract
<jats:sec><jats:title>Objectives</jats:title><jats:p>Computer-administered cognitive–behavioural therapy (CCBT) may be a promising treatment for adolescents with depression, particularly due to its increased availability and accessibility. The feasibility of delivering a randomised controlled trial (RCT) comparing a CCBT program (Stressbusters) with an attention control (self-help websites) for adolescent depression was evaluated.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Single centre RCT feasibility study.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>The trial was run within community and clinical settings in York, UK.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Adolescents (aged 12–18) with low mood/depression were assessed for eligibility, 91 of whom met the inclusion criteria and were consented and randomised to Stressbusters (n=45) or websites (n=46) using remote computerised single allocation. Those with comorbid physical illness were included but those with psychosis, active suicidality or postnatal depression were not.</jats:p></jats:sec><jats:sec><jats:title>Interventions</jats:title><jats:p>An eight-session CCBT program (Stressbusters) designed for use with adolescents with low mood/depression was compared with an attention control (accessing low mood self-help websites).</jats:p></jats:sec><jats:sec><jats:title>Primary and secondary outcome measures</jats:title><jats:p>Participants completed mood and quality of life measures and a service Use Questionnaire throughout completion of the trial and 4 months post intervention. Measures included the Beck Depression Inventory (BDI) (primary outcome measure), Mood and Feelings Questionnaire (MFQ), Spence Children's Anxiety Scale (SCAS), the EuroQol five dimensions questionnaire (youth) (EQ-5D-Y) and Health Utility Index Mark 2 (HUI-2). Changes in self-reported measures and completion rates were assessed by treatment group.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>From baseline to 4 months post intervention, BDI scores and MFQ scores decreased for the Stressbusters group but increased in the website group. Quality of life, as measured by the EQ-5D-Y, increased for both groups while costs at 4 months were similar to baseline. Good feasibility outcomes were found, suggesting the trial process to be feasible and acceptable for adolescents with depression.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>With modifications, a fully powered RCT is achievable to investigate a promising treatment for adolescent depression in a climate where child mental health service resources are limited.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.isrctn.com/ISRCTN31219579?" ext-link-type="uri">ISRCTN31219579</jats:ext-link>.</jats:p></jats:sec>
Original language | English |
---|---|
Pages (from-to) | e012834-e012834 |
Number of pages | 0 |
Journal | BMJ Open |
Volume | 7 |
Issue number | 1 |
Early online date | 27 Jan 2017 |
DOIs | |
Publication status | Published - Jan 2017 |